Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

  • No of slides: 25

These slides provide an overview of the SUNSET study, which examined the impact de-escalation/switch from triple therapy to dual bronchodilator therapy in patients with COPD.

Download